Floxuridine Market

Floxuridine nickname called fluorouracil, deoxyuridine for deoxidation fluorouracil nucleoside derivatives, type in the body after injection into active floxuridine monophosphate, inhibit DNA thymidylic acid synthetase, prevent deoxyuridine acid methylation into DNA thymidylic acid, thus blocking the synthesis of DNA and inhibit the formation of RNA, killing tumor cells, liver toxicity, reproductive toxicity and teratogenic effects.

Floxuridine Market contains market size and forecasts of Floxuridine (FUDR) in global, including the following market information:

Global Floxuridine (FUDR) Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Floxuridine (FUDR) Market Sales, 2017-2022, 2023-2028, (K Pcs)

Global top five Floxuridine (FUDR) companies in 2021 (%)

The global Floxuridine (FUDR) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Floxuridine (FUDR) include Roche, DSM Nutritional, Taiho, Hikma Pharmaceuticals, Bedford Pharmaceuticals, Fresenius Kabi, Shandong New Era Pharmaceutical, Jiangsu Hengrui Pharmaceutical and Jiangsu Shengdi Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Floxuridine (FUDR) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Floxuridine (FUDR) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Floxuridine (FUDR) Market Segment Percentages, by Type, 2021 (%)

Tablets

Capsule

Global Floxuridine (FUDR) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Floxuridine (FUDR) Market Segment Percentages, by Application, 2021 (%)

Liver Cancer

Gastrointestinal Cancer

Breast Cancer

Lung Cancer

Global Floxuridine (FUDR) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)

Global Floxuridine (FUDR) Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Floxuridine (FUDR) revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Floxuridine (FUDR) revenues share in global market, 2021 (%)

Key companies Floxuridine (FUDR) sales in global market, 2017-2022 (Estimated), (K Pcs)

Key companies Floxuridine (FUDR) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Roche

DSM Nutritional

Taiho

Hikma Pharmaceuticals

Bedford Pharmaceuticals

Fresenius Kabi

Shandong New Era Pharmaceutical

Jiangsu Hengrui Pharmaceutical

Jiangsu Shengdi Pharmaceutical

Qilu Pharmaceutical

Zhejiang Guobang Pharmaceutical

Shanghai Luoshi Pharmaceutical

Yangtze Pharmaceutical Group

Zibo Wanjie Pharmaceutical

Zhejiang Haizheng Pharmaceutical

Ningbo Tianheng Pharmaceutical

Shanghai Pacific Pharmaceutica